LINDAHL RICHARD S 4

What Happened

• Richard S. Lindahl, Chief Financial Officer of Emergent BioSolutions, had the company's 2023–2025 performance stock units (PSUs) finally certified on Feb 6, 2026 at a 25% payout. That certification resulted in an actual award of 15,384 shares. To satisfy tax obligations and plan mechanics, 5,642 shares were withheld (treated as a disposition for tax payment) and 46,155 previously reported target shares were returned/cancelled (disposition to issuer).
• The filing reports share-withholding and disposition prices of $10.92 per share: 5,642 shares × $10.92 = $61,611 (tax withholding) and 46,155 shares × $10.92 = $504,013 (cancelled/returned), a combined value of about $565,624. These were administrative actions tied to PSU settlement, not open-market sales.

Key Details

• Transaction date: Feb 6, 2026; Filing date: Feb 10, 2026 (filed within the 2-business-day Form 4 requirement)
• Prices reported: $10.92 per share for both dispositions
• Share movement: 15,384 shares awarded; 5,642 shares withheld for taxes; 46,155 shares disposed to issuer/cancelled (previously reported target shares)
• Footnotes: F1 explains the PSU plan and the 25% payout (resulting award of 15,384 shares vs. 61,539 previously reported). F2 notes shares were withheld to pay taxes on vesting/settlement.
• Shares owned after the transaction: not specified in the provided filing

Context

• PSUs are performance-based awards that convert to shares only if pre-set targets are met; a 25% payout means most previously reported target shares were not issued and were cancelled back to the company.
• The withheld shares reflect routine tax withholding on equity settlements (administrative, not a market sale). The reported “disposition to issuer” reflects cancellation/return of unearned target shares, not a sale to third parties.